Left Ventricular Enlargement, Cardiac Resynchronization Therapy Efficacy, and Impact of MultiPoint Pacing

Area of Science:

• Cardiology
• Electrophysiology
• Medical Devices

Background:

• Left ventricular (LV) epicardial pacing can lead to slow wavefront propagation, potentially limiting cardiac resynchronization therapy (CRT) efficacy.
• Conventional biventricular pacing with single-site LV stimulation may be less effective in patients with LV enlargement.

Purpose of the Study:

• To test the hypothesis that MultiPoint pacing with wide anatomic separation (MPP-AS) mitigates CRT efficacy limitations in patients with LV enlargement.
• To compare the efficacy of MPP-AS versus conventional biventricular single-site pacing in patients with varying degrees of LV enlargement.

Main Methods:

• A multicenter randomized trial involving 506 patients implanted with quadripolar biventricular pacing leads.
• Patients were assigned to either biventricular single-site pacing or MPP-AS (≥30 mm separation) and stratified by median baseline LV end-diastolic volume indexed to height (LVEDVI_Median).
• Outcomes included a clinical composite score, quality of life, LV structural remodeling, and heart failure events/cardiovascular death.

Main Results:

• In patients with LVEDVI_>Median, MPP-AS demonstrated significantly higher clinical composite score response (92% vs. 65%, P=0.023) and improved quality of life compared to biventricular single-site pacing.
• MPP-AS programming showed a trend towards better reverse remodeling and a reduction in heart failure events in patients with LVEDVI_>Median.
• No significant differences in outcomes were observed between MPP-AS and biventricular single-site pacing in patients with LVEDVI_≤Median.

Conclusions:

• Conventional biventricular single-site pacing has limited efficacy in patients with LV enlargement.
• MPP-AS programming yields the greatest response rates and clinical benefits in patients with larger hearts, suggesting its superiority for CRT in this population.